NANOV THERAPEUTICS
NanoV Therapeutics develops a novel-mechanism anti-cancer drug. The compound, known as VPOA-6, has demonstrated high effectiveness in inhibiting tumor growth and combating a wide variety of cancers, with much less cytotoxicity than other leading drugs (Cisplatin, one of the most common first-line anti-cancer treatments). NanoV intends to use their newly discovered mechanism, utilizing redox catalysis, to develop a new class of anti-cancer agents to bring life-saving treatment to cancer patients... . With drug resistance becoming a more pronounced obstacle to cancer treatment, novel mechanisms that demonstrate efficacy and safety have the potential to earn a large market. VPOA-6 significantly suppresses a wide range of cancers, including multi-drug resistant types. The synthesis and purification of VPOA-6 are readily accomplished in eco-friendly circumstances, requiring no toxic waste, and costing significantly less than existing cancer drugs.
NANOV THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Status:
Active
Total Funding:
24.84 K USD
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Fertilligen
Fertilligen develops a novel treatment for male infertility.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Migra Therapeutics
Migra Therapeutics is developing nanotechnology therapies for cancer.
Neovaccine Strategies
Neovaccine Strategies develops a novel immunotherapeutic reagent to act as a prophylactic against P. aeruginosa.
Oregon Therapeutics
Oregon Therapeutics is a developer of new anti-cancer drugs.
Current Employees Featured
Founder
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NanoV Therapeutics
More informations about "NanoV Therapeutics"
NanoV Therapeutics - Crunchbase Company Profile & Funding
NanoV Therapeutics develops a novel-mechanism anti-cancer drug. The compound, known as VPOA-6, has demonstrated high effectiveness in inhibiting tumor growth and combating a …See details»
NanoV Therapeutics - Funding, Financials, Valuation & Investors
NanoV Therapeutics develops a novel-mechanism anti-cancer drug.See details»
Georgia Research Alliance - GRA
NanoV Therapeutics has developed a novel-mechanism anti-cancer drug. The compound, known as VPOA-6, has demonstrated high effectiveness inhibiting tumor growth and combating a …See details»
NanoV Therapeutics - Crunchbase
NanoV Therapeutics, Migra Therapeutics, Neovaccine Strategies, and Oregon Therapeutics are all involved in the biotechnology and pharmaceutical industry.See details»
Nordic Nanovector announces agreement to acquire …
Nordic Nanovector ASA (OSE: NANOV) and Thor Medical AS, a privately held company focused on the production of alpha-emitting radionuclides for cancer treatment, today announce that they have entered into a definitive share …See details»
Nordic Nanovector and APIM Therapeutics Announce Merger …
Nov 10, 2022 · APIM Therapeutics, founded in 2010 in Trondheim, Norway, is a privately held, clinical stage Norwegian biotechnology company developing first-in-class molecules in …See details»
NanoV Therapeutics - Drug pipelines, Patents, Clinical trials
Explore NanoV Therapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
NanoV Therapeutics LLC.: Drug pipelines, Patents, Clinical trials
Jul 13, 2023 · Explore NanoV Therapeutics LLC. with its drug pipeline, therapeutic area, technology platform, .See details»
Jie (Jay) Song - Founder&President - NanoV Therapeutics - LinkedIn
Faculty, Fellow, School of Medicine at Emory University - Founder at Flourishing International Education; - Founder at NanoV Therapeutic; - Co-Founder at Cure Pharma; · Experience: …See details»
Nordic Nanovector to acquire Thor Medical - scatecinnovation.no
Jun 7, 2023 · Nordic Nanovector ASA (OSE: NANOV) and Thor Medical AS, a privately held company focused on the production of alpha-emitting radionuclides for cancer treatment, …See details»
Nordic Nanovector ASA - Drug pipelines, Patents, Clinical trials
Nov 1, 2024 · Abstract Purpose: 177 Lu-lilotomab satetraxetan, a novel CD37 directed radioimmunotherapy (RIT), has been investigated in a first-in-human phase 1/2a study for …See details»
Thor Medical Stock (NANOV) - Quote Oslo Bors- MarketScreener
The Company is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product is Betalutin, a CD37-targeting radio-immunoconjugate …See details»
NANOV: Nordic Nanovector and APIM Therapeutics Announce …
Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") and all shareholders of APIM Therapeutics ("APIM"), a privately held, clinical-stage cancer-focused …See details»
Nordic Nanovector comment on Proposed Merger with APIM …
Nov 21, 2022 · Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company’s …See details»
NanoV Therapeutics - Contacts, Employees, Board Members
NanoV Therapeutics develops a novel-mechanism anti-cancer drug.See details»
NTx partnership with Novo Nordisk - NanoVation Therapeutics
Sep 18, 2024 · The partnership combines NanoVation Therapeutics’ proprietary long-circulating lipid nanoparticle (lcLNPâ„¢) technology for RNA delivery to cells outside of the liver with Novo …See details»
Nutcracker Therapeutics Presents Precision Biomanufacturing and …
3 days ago · EMERYVILLE, Calif., November 25, 2024--Nutcracker Therapeutics will introduce its CRDMO capabilities to provide scalable biomanufacturing services for RNA drug developers.See details»
Founder and President @ NanoV Therapeutics - Crunchbase
Jie Jay Song is the Founder and President at NanoV Therapeutic. Jie attended the Emory University.See details»
Farris Represents NanoVation Therapeutics in Multi-Target …
Oct 4, 2024 · The partnership combines NanoVation Therapeutics’ proprietary long-circulating lipid nanoparticle (lcLNPâ„¢) technology for RNA delivery to cells outside of the liver with Novo …See details»
Delivery of cancer therapies by synthetic and bio-inspired …
Mar 24, 2021 · The advent of nanotechnologies opened an entirely novel area of research around the nanovectorization of anti-tumor therapeutics to both increase treatment efficacy and …See details»